Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · IEX Real-Time Price · USD
0.414
-0.017 (-3.84%)
At close: Mar 28, 2024, 4:00 PM
0.405
-0.008 (-2.03%)
After-hours: Mar 28, 2024, 7:10 PM EDT
Cybin Market Cap
Cybin has a market cap or net worth of $326.06 million as of March 28, 2024. Its market cap has increased by 354.76% in one year.
Market Cap
326.06M
Enterprise Value
297.52M
1-Year Change
354.76%
Ranking
Category
Stock Price
$0.41
Market Cap Chart
Since August 5, 2021, Cybin's market cap has decreased from $434.60M to $326.06M, a decrease of -24.97%. That is a compound annual growth rate of -10.30%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 176.80M | 0.23% |
Mar 26, 2024 | 176.40M | 0.23% |
Mar 25, 2024 | 176.00M | 2.62% |
Mar 22, 2024 | 171.50M | 2.45% |
Mar 21, 2024 | 167.40M | -3.07% |
Mar 20, 2024 | 172.70M | -5.21% |
Mar 19, 2024 | 182.20M | -1.51% |
Mar 18, 2024 | 185.00M | -2.22% |
Mar 15, 2024 | 189.20M | 7.26% |
Mar 14, 2024 | 176.40M | 2.14% |
Mar 13, 2024 | 172.70M | -4.53% |
Mar 12, 2024 | 180.90M | 10.24% |
Mar 11, 2024 | 164.10M | 2.05% |
Mar 8, 2024 | 160.80M | 6.28% |
Mar 7, 2024 | 151.30M | 15.32% |
Mar 6, 2024 | 131.20M | -0.30% |
Mar 5, 2024 | 131.60M | -3.02% |
Mar 4, 2024 | 135.70M | -1.52% |
Mar 1, 2024 | 137.80M | -3.70% |
Feb 29, 2024 | 143.10M | - |
Feb 28, 2024 | 143.10M | - |
Feb 27, 2024 | 143.10M | -0.56% |
Feb 26, 2024 | 143.90M | -6.68% |
Feb 23, 2024 | 154.20M | -5.80% |
Feb 22, 2024 | 163.70M | 3.94% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Procaps Group | 338.47M |
AirSculpt Technologies | 337.64M |
ModivCare | 334.65M |
Nautilus Biotechnology | 331.51M |
Kamada | 329.99M |
Bioventus | 325.13M |
AxoGen | 324.48M |
Atea Pharmaceuticals | 321.51M |